| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 727273 | 84607 | CONFEROPORT 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 0,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84607/84607_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84607/84607_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-11-12 | 1 | 1 | 1 | 2019-11-12 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727324 | 84629 | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 1 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84629/84629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84629/84629_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727325 | 84629 | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 60 cápsulas | 1 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84629/84629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84629/84629_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727326 | 84630 | CONFEROPORT 2 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | CONFEROPORT 2 MG CAPSULAS DURAS DE LIBERACION PROLONGADA , 30 cápsulas | 2 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84630/84630_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84630/84630_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727327 | 84631 | CONFEROPORT 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84631/84631_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84631/84631_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 727328 | 84632 | CONFEROPORT 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | CONFEROPORT 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84632/84632_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84632/84632_p.pdf | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-01-10 | View Edit Delete | ||||||||||||
| 728099 | 1191417 | BEOVU 120 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA | BEOVU 120 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,165 ml | 120 mg/ml inyectable 0,165 ml | 33 | 1 | 61 | 1 jeringa precargada de 0,165 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191417/1191417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191417/1191417_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2020-02-28 | 1 | 1 | 1 | 2020-02-29 | 2020-02-28 | 1 | 2022-04-11 | View Edit Delete | ||||||||||||
| 727309 | 1171229010 | DUPIXENT 200 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA | DUPIXENT 200 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 1,14 ml | 200 mg inyectable 1,14 ml | 33 | 2 | 61 | 2 jeringas precargadas de 1,14 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1171229010/1171229010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1171229010/1171229010_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2019-12-10 | 1 | 1 | 1 | 2019-12-11 | 2019-12-10 | 1 | 2022-06-07 | View Edit Delete | ||||||||||||
| 727646 | 1191406001 | BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS | BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS, 1 envase unidosis | 3 mg/dosis | 37 | 1 | 37 | 1 envase unidosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191406001/1191406001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191406001/1191406001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16616 | AMPHASTAR FRANCE PHARMACEUTICALS | 2020-01-17 | 1 | 1 | 1 | 2020-01-18 | 2020-01-17 | 1 | 2020-12-11 | View Edit Delete | ||||||||||||
| 728211 | 1201428001 | GIVLAARI 189 MG/ML SOLUCION INYECTABLE | GIVLAARI 189 MG/ML SOLUCION INYECTABLE, 1 vial de 1 ml | 189 mg/ml inyectable 1 ml | 45 | 1 | 34 | 1 vial de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201428001/1201428001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201428001/1201428001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 35404 | ALNYLAM PHARMACEUTICALS SPAIN S.L. | 2020-04-28 | 1 | 1 | 1 | 2020-04-29 | 2020-04-28 | 1 | 2021-08-02 | View Edit Delete | ||||||||||||
| 727843 | 1191388001 | POLIVY 140 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | POLIVY 140 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 140 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1191388001/1191388001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1191388001/1191388001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29096 | ROCHE FARMA S.A. | 2020-02-18 | 1 | 1 | 1 | 2020-02-19 | 2020-02-18 | 1 | 2021-08-27 | View Edit Delete | ||||||||||||
| 727616 | 84735 | UROQUINASA SYNER MEDICA 10.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION | UROQUINASA SYNER MEDICA 10.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION 1 vial | 10.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84735/84735_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84735/84735_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35023 | MANA PHARMA S.L. | 2019-12-16 | 1 | 1 | 1 | 2019-12-17 | 2019-12-16 | 1 | 2026-01-12 | View Edit Delete | ||||||||||||
| 727617 | 84736 | UROQUINASA SYNER MEDICA 100.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION | UROQUINASA SYNER MEDICA 100.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION 1 vial | 100.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84736/84736_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84736/84736_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35023 | MANA PHARMA S.L. | 2019-12-16 | 1 | 1 | 1 | 2019-12-17 | 2019-12-16 | 1 | 2022-11-22 | View Edit Delete | ||||||||||||
| 727618 | 84737 | UROQUINASA SYNER MEDICA 25.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION | UROQUINASA SYNER MEDICA 25.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION 1 vial | 25.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84737/84737_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84737/84737_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35023 | MANA PHARMA S.L. | 2019-12-16 | 1 | 1 | 1 | 2019-12-17 | 2019-12-16 | 1 | 2026-01-12 | View Edit Delete | ||||||||||||
| 727619 | 84738 | UROQUINASA SYNER MEDICA 250.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION | UROQUINASA SYNER MEDICA 250.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION 1 vial | 250.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84738/84738_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84738/84738_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35023 | MANA PHARMA S.L. | 2019-12-16 | 1 | 1 | 1 | 2019-12-17 | 2019-12-16 | 1 | 2022-12-07 | View Edit Delete | ||||||||||||
| 727620 | 84739 | UROQUINASA SYNER MEDICA 500.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION | UROQUINASA SYNER MEDICA 500.000 U.I. POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION 1 vial | 500.000 UI | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84739/84739_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84739/84739_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35023 | MANA PHARMA S.L. | 2019-12-16 | 1 | 1 | 1 | 2019-12-17 | 2019-12-16 | 1 | 2023-07-25 | View Edit Delete | ||||||||||||
| 727090 | 1151024002IP | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP/1151024002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP/1151024002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | ABACUS MEDICINE A/S | 2019-10-17 | 1 | 1 | 1 | 2019-10-18 | 2019-10-17 | 1 | 2020-03-19 | View Edit Delete | ||||||||||||
| 727306 | 113813001IP | PERJETA 420 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | PERJETA 420 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 14 ml | 420 mg inyectable 14 ml | 45 | 1 | 34 | 1 vial de 14 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113813001IP/113813001IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113813001IP/113813001IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ABACUS MEDICINE A/S | 2019-11-06 | 1 | 1 | 1 | 2019-11-07 | 2019-11-06 | 1 | 2022-05-18 | View Edit Delete | ||||||||||||
| 727329 | 1151014002IP | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | OPDIVO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 10 ml | 10 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151014002IP/1151014002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151014002IP/1151014002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31892 | ABACUS MEDICINE A/S | 2019-11-12 | 1 | 1 | 1 | 2019-11-13 | 2019-11-12 | 1 | 2020-03-31 | View Edit Delete | ||||||||||||
| 727713 | 114957003IP | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | CYRAMZA 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION 1 vial de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114957003IP/114957003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114957003IP/114957003IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 20183 | ABACUS MEDICINE A/S | 2020-01-14 | 1 | 1 | 1 | 2020-01-15 | 2020-01-14 | 1 | 2020-05-15 | View Edit Delete |
Page 55 of 1036, showing 20 records out of 20704 total, starting on record 1081, ending on 1100